000 01326 a2200361 4500
005 20250514235946.0
264 0 _c20060214
008 200602s 0 0 eng d
022 _a1744-764X
024 7 _a10.1517/14740338.4.5.821
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDi Perri, Giovanni
245 0 0 _aDrug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.
_h[electronic resource]
260 _bExpert opinion on drug safety
_cSep 2005
300 _a821-36 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Retroviral Agents
_xadverse effects
650 0 4 _aAntitubercular Agents
_xadverse effects
650 0 4 _aComorbidity
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aDrug Interactions
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aTuberculosis, Pulmonary
_xcomplications
700 1 _aAguilar Marucco, Diego
700 1 _aMondo, Alessandra
700 1 _aGonzalez de Requena, Daniel
700 1 _aAudagnotto, Sabrina
700 1 _aGobbi, Federico
700 1 _aBonora, Stefano
773 0 _tExpert opinion on drug safety
_gvol. 4
_gno. 5
_gp. 821-36
856 4 0 _uhttps://doi.org/10.1517/14740338.4.5.821
_zAvailable from publisher's website
999 _c15748532
_d15748532